Katie Hasson
$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs
In a much-anticipated move, the Federal Drug Administration (FDA) has approved two new gene therapies for sickle cell disease ...
Viewpoint: Debating the debate over the new stem cell research guidelines
An organization of scientists is recommending that limitations on several experimental and controversial research procedures – including heritable genome editing, ...
Will gene editing human embryos ever be safe?
Debates continue about whether the societal risks of heritable genome editing are too great to proceed, as do calls for ...
100+ countries have outlined legal restrictions on editing human embryos. Here’s a guide
Discussions and debates about the governance of human germline and heritable genome editing should be informed by a clear and ...
Viewpoint: We don’t need another study to convince us that gene-edited babies are a bad idea
He [Jiankui] attempted to disable a gene called CCR5 by producing a variant that has been shown to confer resistance ...
